NCT06718608

Brief Summary

We propose to carry out a single center, prospective, interventional trial to assess the natural evolution of lower limb muscle structure and muscle stiffness of hemiparetic patients following brain damage. Patients will be assessed two weeks, one month, three months and six months after their brain lesion. Secondary objectives: To compare the muscle stiffness and structure of patients who will develop muscle overactivity to patients who won't develop muscle overactivity. To compare the muscle structure and muscle stiffness of the spastic lower limb muscles and the non-spastic lower limb muscles in the affected limb. To compare the muscle structure and muscle stiffness of the affected and the non-affected lower limb. To study the relationship between impairment and function by applying a comprehensive and original method to assess all aspects from muscle structure and mechanics to patient's functional capacities.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2024

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 2, 2024

Completed
Same day until next milestone

Study Start

First participant enrolled

December 2, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

December 5, 2024

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2026

Completed
Last Updated

December 5, 2024

Status Verified

December 1, 2024

Enrollment Period

1.1 years

First QC Date

December 2, 2024

Last Update Submit

December 2, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Muscle elasticity

    Muscle elasticity measured by shear wave elastography, expressed in m/s. A smaller shearwave velocity indicates a better outcome

    2 weeks, 1 month, 3 months, 6 months after brain lesion

Secondary Outcomes (2)

  • muscle volume

    2 weeks, 1 month, 3 months, 6 months after brain lesion

  • muscle fat fraction

    2 weeks, 1 month, 3 months, 6 months after brain lesion

Other Outcomes (10)

  • passive range of motion

    2 weeks, 1 month, 3 months, 6 months after brain lesion

  • modified ashworth scale

    2 weeks, 1 month, 3 months, 6 months after brain lesion

  • modified Tardieu scale

    2 weeks, 1 month, 3 months, 6 months after brain lesion

  • +7 more other outcomes

Study Arms (1)

Only one arm

EXPERIMENTAL
Diagnostic Test: imaging

Interventions

imagingDIAGNOSTIC_TEST

Magnetic resonance imaging (MRI) Shear wave elastography (SWE) Electronic oscillatory device (EOD)

Only one arm

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Female or male ≥ 18 years and ≤ 80 years at screening
  • Hemiparesis secondary to a first stroke or traumatic brain injury

You may not qualify if:

  • Bilateral limb paresis
  • Major cognitive impairments limiting the functional evaluation
  • Neurological or orthopedic affection interfering with the paretic limbs function
  • Underlying neuromuscular disease (e.g. myasthenia gravis, Lambert-Eaton syndrome, amyotrophic lateral sclerosis)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cliniques Universitaires Saint-Luc

Brussels, 1200, Belgium

Location

MeSH Terms

Conditions

StrokeBrain Injuries, Traumatic

Interventions

Diagnostic Imaging

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesBrain InjuriesCraniocerebral TraumaTrauma, Nervous SystemWounds and Injuries

Intervention Hierarchy (Ancestors)

Diagnostic Techniques and ProceduresDiagnosis

Study Officials

  • Gaetan Stoquart, MD, PhD

    Cliniques universitaires Saint-Luc- Université Catholique de Louvain

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 2, 2024

First Posted

December 5, 2024

Study Start

December 2, 2024

Primary Completion

December 31, 2025

Study Completion

March 1, 2026

Last Updated

December 5, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Locations